#VisualAbstract Brentuximab vedotin with nivolumab was well-tolerated and showed durable remissions as initial salvage therapy in relapsed/refractory classic Hodgkin’s Lymphoma
RelatedReports
Popular Reports
-
Ultrasound features associated with shoulder complaints
-
Automated pupillometry may be helpful in opioid agonist therapy dosing for opioid use disorder
-
Logistical barriers may impact access to contraceptive use amongst females with opioid use disorder
-
#VisualAbstract: Adequate antibody response to mRNA-1273 COVID-19 vaccine occurs in patients with cancer
-
Geriatric assessment and management may reduce adverse events in older cancer patients
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.